Investor transparency on corporates’ decarbonisation strategies could require review of SRD II or introduction of European stewardship code.
Investors emphasise the need for companies to increase voluntary licensing of medicines, after new benchmark report reveals slowdown.
Timeline, scope of regulation currently uncertain, as new proposal seeks to increase quality, transparency and comparability.
A selection of the major stories impacting ESG investors, in five easy pieces.
Gilad Tanay, Founder of ERI Institute, advises on how to ensure that disclosures don’t become a distraction.
Regenerative agriculture’s outcomes-based approach offers strong financial and sustainable returns, says Richard Jacobs, Head of the Farmland Strategy at Van Lanschot Kempen.
Rachel Richardson, Head of ESG at Macfarlanes, outlines the next steps and potential implications of a UK Green Taxonomy.
Private equity firms can create positive social impact by investing in job quality and cultivating an engaged workforce, says Tim Bubnack at...
Investor feedback to SDI AOP highlights demand for forward-looking insights on technology trends to meet sustainability objectives.
Words may not always match actions in Trump’s second presidency, as investors are told to keep calm and carry on.
Subscribe to our free weekly newsletter below and never miss a story.